StreetInsider.com News Articles

Medical Marijuana, Inc. Portfolio Investment Company Neuropathix Announces Grant Award for Parkinson's Research

Wed, 26 Jun 2024 09:09:00 -0400

SAN DIEGO, CA - (NewMediaWire) - June 26, 2024 - Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), announced today that Kannalife Sciences, Inc. (Kannalife"), a wholly-owned subsidiary of the Company's portfolio investment company Neuropathix, Inc., a pioneering biotech company specializing in the development of small molecule synthetic cannabinoid therapeutics targeting inflammation, was awarded grant funding of $1.49 million for its Parkinsons research using its Cannabinoid Therapeutic KLS-13019. The Company owns approximately 22% of Neuropathix.

Read the full Press Release here: https://www.globenewswire.com/news-release/2024/06/25/2903784/0/en/Kannalife-Secures-Funding-of-1-49-Million-from-The-Michael-J-Fox-Foundation-for-Parkinson-s-Research.html

Medical Marijuana, Inc. Chairman and CEO, Tim Scott, commented on the news; "We are one of Neuropathixs largest shareholders and the securing of this grant to its wholly-owned subsidiary Kannalife is a

Medical Marijuana, Inc. Portfolio Investment Company Neuropathix Announces Grant Award for Parkinson's Research

Wed, 26 Jun 2024 09:09:00 -0400

Medical Marijuana, Inc. Portfolio Investment Company Neuropathix Announces Grant Award for Parkinson's Research

Wed, 26 Jun 2024 09:09:00 -0400

Medical Marijuana, Inc. Portfolio Investment Company Neuropathix Announces Grant Award for Parkinson's Research

Wed, 26 Jun 2024 09:09:00 -0400

Medical Marijuana, Inc. Portfolio Investment Company Neuropathix Announces Grant Award for Parkinson's Research

Wed, 26 Jun 2024 09:09:00 -0400

Medical Marijuana, Inc. Portfolio Investment Company Neuropathix Announces Grant Award for Parkinson's Research

Wed, 26 Jun 2024 09:09:00 -0400

Medical Marijuana, Inc. Portfolio Investment Company Neuropathix Announces Grant Award for Parkinson's Research

Wed, 26 Jun 2024 09:09:00 -0400

Medical Marijuana, Inc. Portfolio Investment Company Neuropathix Announces Grant Award for Parkinson's Research

Wed, 26 Jun 2024 09:09:00 -0400

Medical Marijuana, Inc. Kannaway Division Completes Acquisition of KZ1 Network Marketing Company

Tue, 01 Aug 2023 09:00:00 -0400

SAN DIEGO--(BUSINESS WIRE)-- Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), announced today that its network marketing division, Kannaway, has completed an Asset Purchase Agreement with eXfuse, LLC, dba KZ1 a Japan based network marketing company. The KZ1 acquisition will increase the sales force of the Company’s Kannaway division in Japan by approximately 1,450 individuals and the Company believes the increased sales force will greatly benefit Kannaway’s ramp up in the Japanese market. KZ1’s premium product “Focus,” containing Nootropics, which helps support cognitive function, has been well received in the Japanese market and adds

Medical Marijuana, Inc. Kannaway Division Completes Acquisition of KZ1 Network Marketing Company

Tue, 01 Aug 2023 09:00:00 -0400

Medical Marijuana, Inc. Kannaway Division Completes Acquisition of KZ1 Network Marketing Company

Tue, 01 Aug 2023 09:00:00 -0400

Medical Marijuana, Inc. Kannaway Division Completes Acquisition of KZ1 Network Marketing Company

Tue, 01 Aug 2023 09:00:00 -0400

Medical Marijuana, Inc. Kannaway Division Completes Acquisition of KZ1 Network Marketing Company

Tue, 01 Aug 2023 09:00:00 -0400

Medical Marijuana, Inc. Kannaway Division Completes Acquisition of KZ1 Network Marketing Company

Tue, 01 Aug 2023 09:00:00 -0400

Medical Marijuana, Inc. Kannaway Division Completes Acquisition of KZ1 Network Marketing Company

Tue, 01 Aug 2023 09:00:00 -0400

Medical Marijuana, Inc. Kannaway Division Completes Acquisition of KZ1 Network Marketing Company

Tue, 01 Aug 2023 09:00:00 -0400

Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion